A meta-analysis revealed that the detection of mucin 5AC (MUC5AC) in sera could be used as a powerful biomarker of CCA by providing a specificity of up to 97% and sensitivity of 63% [16,17,18]. Here, MUC5AC is linked to cholangiocarcinoma.